Riyadh, Saudi Arabia — Saudi-based health and longevity startup Madeed has raised $400,000 in a pre-seed investment round, led by Vision Ventures (VV), with participation from angel investors Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
Founded by Adam Batayneh, Madeed is building a technology-driven platform focused on health, prevention, and longevity, aiming to improve quality of life through early disease detection and proactive healthcare.
The platform relies on advanced laboratory testing and data analysis to identify early warning signals for hundreds of diseases before symptoms appear, enabling individuals to take preventive action and manage long-term health more effectively.
The newly raised capital will be used to launch Madeed’s product, expand its clinical and laboratory partnerships, and roll out the first cohort of members, with an initial focus on the Saudi Arabian market.
With increasing demand for preventive healthcare and longevity-focused solutions in the Kingdom, Madeed positions itself at the intersection of healthtech, diagnostics, and personalized medicine, supporting Saudi Arabia’s broader vision for innovation and improved population health.
